Seratrodast

CAS: 112665-43-7

Ref. TM-T0212

Produktinformation

• Name: Seratrodast
• Synonyme: AA 2414, ABT-001, (+-)-2,4,5-Trimethyl-3,6-dioxo-zeta-phenyl-1,4-cyclohexadiene-1-heptanoic acid, (+-)-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid, (±)-2,4,5-Trimethyl-3,6-dioxo-ζ-phenyl-1,4-cyclohexadiene-1-heptanoic acid, 7-(2,4,5-Trimethyl-3,6-Dioxocyclohexa-1,4-Dienyl)-7-Phenylheptanoic Acid, 7-Phenyl-7-(2,4,5-Trimethyl-3,6-Dioxocyclohexa-1,4-Dien-1-Yl)Heptanoic Acid, A 73001, Aa-2414, Abbott 73001, Abt 001, Benzeneheptanoic acid, zeta-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, (+-)-, Benzeneheptanoic acid, ζ-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, Bronica, Ccris 8939, Seratodrast, Seratrodast [USAN:INN], Unii-4U58Jm421N, methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate, ζ-(2,4,5-Trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)benzeneheptanoic acid
• CAS: 112665-43-7

Beschreibung

Seratrodast (ABT-001) (INN), a thromboxane A2 (TXA2) receptor (TP receptor) antagonist, is mainly used in the therapy of asthma. It was the first TP receptor antagonist developed as an anti-asthmatic drug and attained marketing qualification in Japan in 1997.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 354.44
• Formel: C₂₂H₂₆O₄
• Reinheit: 99.12%
• Farbe/Form: Pale Orange Solid